Politico January 17, 2026
David Lim

David Ricks, CEO of the Indiana drugmaker, has cut deals with the president to slash prices and build American. Trump has showered him with praise.

Corporate CEOs trying to figure out how to get on President Donald Trump’s good side need look no further. David Ricks, CEO of the Indianapolis-based pharmaceutical manufacturer Eli Lilly, is putting on a masterclass.

Trump demonstrated his affection on Friday when he — not for the first time — praised the company executive.

“The head of Eli Lilly, and I really mean it, an unbelievable executive, an unbelievable guy, one of the most successful companies,” Trump said during remarks about his “Great Healthcare Plan.”

For his part, over Trump’s second term, Ricks, who took Eli...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal

Share Article